Nail & Skin Disorders

A Day in the Life of a Nail Expert: Nail Fungus

In this month’s column, Dr. Stern discusses who is particularly at risk to contract nail fungus and what treatment options are available to those who do get it.  

When we think about nail infections, fungus is probably what first comes to mind. It turns out that onychomycosis (nail fungus) is extremely common, as an estimated 35 million people in the U.S. are infected. It’s important to understand what makes us vulnerable to nail fungus, and why it’s important to treat it. Several treatment options are currently available, each offering pros and cons.

 

Who Is Vulnerable?

We are all exposed to fungus in our environment, yet not everyone acquires the infection. Our vulnerability is dependent on the complex interplay between our genetics, age, habits, other medical issues, and the environment. Simply being older is a risk factor, as more than 50% of nail fungus cases are seen in those over the age of 70. As we age, our toenails change due to years of chronic, repetitive micro trauma. Once the nail starts to grow abnormally, we become vulnerable to acquiring fungus. Aging also brings slower nail growth, another factor that predisposes a person to fungal acquisition.

Certain medical conditions can also make us more susceptible to fungus, such as diabetes, peripheral vascular disease, psoriasis, and HIV. Toenail trauma, common with certain athletic activities, such as tennis, skiing, and running, can lead to onychomycosis. Once the nail is damaged and lifted away from the nail bed, the protective barrier is compromised and fungus in the environment or on neighboring skin can enter the nail unit. Excessive foot sweating, poor hygiene, and unprotected communal exposure (i.e., bare feet in the gym locker room) can also put a person at risk.

 

Why Treat Fungus?

For many, nail fungus is cosmetically unappealing and the rationale to treat it is purely for aesthetic reasons. Most sufferers do not realize there are important medical reasons why treatment can be imperative. For one, fungus can spread to other toenails, the hands, the fingernails, or other skin sites. Thick, infected nails can be hard to maintain, may become painful, and can even make walking difficult. Fungus on the toenails is also a very common cause of bacterial infections on the skin at the lower legs (lower extremity cellulitis). This occurs when microscopic breaks in the skin become infected with bacteria.

 

Treatment Options

Treatment options can be divided into three categories: oral agents, topical agents, and non-pharmacologic approaches to therapy. Oral agents are prescriptions pills such as Terbinafine (Lamisil), Itraconazole, or Fluconazole. These are medications that must be prescribed by a physician. We have a lot of experience with these medications as they have been on the market for years. Dosing and treatment duration depends on the type of fungus and the severity of the case being treated. These oral medications have had rare but serious side effects associated with them, including liver and cardiac toxicity; therefore, laboratory monitoring is important. Also, these oral agents can interact with other common medications. For these reasons, many patients and physicians shy away from oral agents and prefer to use topical therapies.

Topical fungal medications are advantageous because they have fewer side effects and do not require laboratory monitoring. The disadvantage is that they are less effective and patients tend to be less compliant with these treatments because the treatment courses are longer. Until recently, the only prescription topical antifungal agent that was approved in the U.S. was Ciclopirox lacquer (Penlac). More recently, two new prescription topical antifungals have been approved and have demonstrated superior efficacy. Efinaconazole 10% solution (Jublia) was approved in June 2014 and Tavaborole 5% solution (Kerydin) was approved in July 2014 for the treatment of onychomycosis. For toenails, treatment is daily for 48 weeks. Both of these drugs have very safe profiles and are exciting additions to our antifungal arsenal.

Non-pharmacologic approaches to therapy include mechanical nail removal, laser treatment, and chemical removal of the nail. Mechanical nail removal — surgical removal of the nail plate — tends to be a method that is favored by podiatrists. The procedure requires numbing the toe and removing the nail in order to reduce fungal load and remove a very thick nail that is not likely to respond well to therapy. When toenails are extremely thick and it is less likely that a topical medication will be able to penetrate effectively, this can be a beneficial option. Lasers always have appeal to consumers because they are high-tech and thought of as the latest in technology. Currently, short-pulse Nd-Yag lasers are approved in the U.S. for the temporary improvement of fungal nails. These devices are still considered controversial, as their efficacy is questionable and many believe that they have not yet been adequately studied. The last of the non-pharmacologic approaches, chemical removal, involves using a urea-based prescription cream and applying it to the nail repetitively. Urea breaks down keratin and can soften even very thick nails. Over time the nail will crumble and become easier to remove without the need for surgery.

 

Dr. Dana Stern
<p>Dr. Dana Stern</p>

 

Dermatologists treat skin, hair, and nails. I am a board-certified dermatologist and I specialize in the treatment of nail disorders including inflammatory diseases of the nail, cosmetic issues, cancers of the nail, sports-related injuries, and nail infections.

 

 

 

Read previous “Day in the Life” articles by Dr. Stern at www.nailsmag.com/danastern.

You can contact Dr. Stern with your questions via Facebook (www.facebook.com/danasternmd) or Twitter (@DrDanaStern). Visit her website at www.drdanastern.com.

 

 

Facebook Comments ()

Leave a Comment

Name:
Email:
Comment:
Submit

Comments (0)

Subscribe to NAILS & SAVE!

Get a free preview issue and a Free Gift
Subscribe Today!

Please sign in or register to .    Close
Loading...
 
Subscribe Today
Subscribe Today